Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × tazemetostat × Other solid neoplasm × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 4 Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Genitourinary 1

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Rhabdoid Tumor 1 Mesothelioma, Malignant 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma 1 Carcinoma, Renal Cell 1

Interventions

tazemetostat 1 osunprotafib 1 omburtamab I-131 1 molibresib 1 marizomib 1 Pemetrexed 1 Cisplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available

GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡